What is the price-to-earnings ratio of Mediclin?
The price-earnings ratio of Mediclin is currently 0.19.
Mediclin P/S 2024
Mediclin P/S
0.19
Ticker
MED.DE
ISIN
DE0006595101
WKN
659510
As of Dec 18, 2024, Mediclin's P/S ratio stood at 0.19, a 0% change from the 0.19 P/S ratio recorded in the previous year.
The Mediclin P/S history
Mediclin Aktienanalyse
What does Mediclin do?
Mediclin AG is a German company specializing in the care and treatment of patients. It was founded in 1984 in Berlin and has since relocated its headquarters to Offenburg. Mediclin operates over 50 healthcare facilities throughout Germany, including hospitals, rehabilitation centers, nursing facilities, and medical care centers. The company employs approximately 10,000 employees and generated a revenue of 1.17 billion euros in 2020. Mediclin ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Mediclin's P/S Ratio
Mediclin's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Mediclin's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Mediclin's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Mediclin’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Mediclin stock
How has the price-earnings ratio of Mediclin changed compared to last year?
The price-to-earnings ratio of Mediclin has increased by 0% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Mediclin high compared to other companies?
Yes, the price-to-earnings ratio of Mediclin is high compared to other companies.
How does an increase in the price-earnings ratio of Mediclin affect the company?
An increase in the price-earnings ratio of Mediclin would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Mediclin affect the company?
A decrease in the price-earnings ratio of Mediclin would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Mediclin?
Some factors that influence the price-earnings ratio of Mediclin are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Mediclin pay?
Over the past 12 months, Mediclin paid a dividend of 0.05 EUR . This corresponds to a dividend yield of about 2.07 %. For the coming 12 months, Mediclin is expected to pay a dividend of 0.1 EUR.
What is the dividend yield of Mediclin?
The current dividend yield of Mediclin is 2.07 %.
When does Mediclin pay dividends?
Mediclin pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Mediclin?
Mediclin paid dividends every year for the past 3 years.
What is the dividend of Mediclin?
For the upcoming 12 months, dividends amounting to 0.1 EUR are expected. This corresponds to a dividend yield of 4.29 %.
In which sector is Mediclin located?
Mediclin is assigned to the 'Health' sector.
Wann musste ich die Aktien von Mediclin kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Mediclin from 6/3/2019 amounting to 0.05 EUR, you needed to have the stock in your portfolio before the ex-date on 5/30/2019.
When did Mediclin pay the last dividend?
The last dividend was paid out on 6/3/2019.
What was the dividend of Mediclin in the year 2023?
In the year 2023, Mediclin distributed 0 EUR as dividends.
In which currency does Mediclin pay out the dividend?
The dividends of Mediclin are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Mediclin stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Mediclin
Our stock analysis for Mediclin Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mediclin Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
